The World Health Organization has just issued updated WHO guidelines on TB infection prevention and control. These guidelines outline a new evidence-based framework that promotes the implementation of an integrated package of Infection Prevention & Control (IPC) interventions based on administrative, engineering, and respiratory protection controls. This will contribute to cutting transmission and reducing the burden of TB illness and death to reach the global targets of the End TB Strategy and the political declaration of the UN High Level meeting on TB.

The WHO Global TB Program has developed and is supporting country implementation of a new digital platform to store, analyze and visualize national and subnational TB surveillance data. The platform will facilitate timely planning and programmatic action.

WHO issues new guidance to improve treatment of multidrug-resistant TB.

WHO has facilitated the creation of a new expert group on drug-resistant tuberculosis (DR-TB) to support Member States in improving their research on treatment. The areas of focus of the group, part of the WHO European Tuberculosis Research Initiative (ERI-TB), were agreed at a planning meeting in Vienna, Austria, on 22 February 2019.

Every hour 30 people are diagnosed with TB in the European Region. It’s time to make TB a disease of the past.

The World Health Organization’s (WHO) revamped Civil Society Task Force on TB (CSTF) held its first meeting on 7-8 March to identify key priorities for the period 2019-2020.

The World Health Organization releases advocacy and communications materials to support awareness building and promotion in the lead up to and on World TB Day.

The World Health Organization (WHO) Executive Board reviewed a report of the WHO Director-General on the follow-up to the UN High-Level Meeting on TB held in September 2018.

25 January 2018 | Seoul, Republic of Korea – An outcome statement to step up action to end TB was released today outlining pledges of support from civil society, countries and partners. The statement highlights key opportunities, actions and next steps to empower and strengthen community and civil society engagement to end TB, and is the culmination of a landmark consultation organized by the WHO Regional Office of the Western Pacific and the Korean Institute of Tuberculosis (KIT) on 11-13 December. The workshop brought together more than 40 participants from countries and partners, including the regional members of the revamped WHO Civil Society Task Force to strengthen global and regional mechanisms for civil society engagement.

A new Tuberculosis Regional Eastern European and Central Asian Project, referred to as TB-REP 2.0, has been launched. This project for 2019 to 2022, building on the previous TB-REP from 2016 to 2018, will consolidate past achievements and address new and remaining challenges while ensuring continuity. In particular, it will focus on improving tuberculosis (TB) prevention and care outcomes.